Delivery Order SPE2DB22D2206-SPE2DB24FJA57

Award Date 7/2/24
Potential Completion Date 7/3/24
Potential Value $3.9K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,412.10 firm fixed-price delivery order is for Tacrolimus 1 mg capsules, with an ultimate completion date of October 28, 2021. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award, valued at $3,710.04, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, Corporate Office Division. The contract is for the delivery of 4566043689 - TACROLIMUS 1 MG CAPSULE (IR) 100S, a pharmaceutical product. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of October 8, 2024. This award is not set-aside and is part of Amerisourcebergen's larger Indefinite...
This is a delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The $14,773.24 firm-fixed-price contract is for the delivery of Tacrolimus 5 mg capsules, an immunosuppressant medication. The contract has a period of performance through June 11, 2025 and is not set aside for any particular business type. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,161.30, is for the delivery of 100 units of TACROLIMUS 1 MG CAPSULE (IR). This contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., which holds a significant Indefinite Delivery Contract...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp. The award is for the delivery of TACROLIMUS 5 MG CAPSULE (IR) 100S, a pharmaceutical product. The contract has a total ceiling value of $19,249.30 and is a Firm Fixed Price Delivery Order type contract. The contract has no set-aside designation, indicating open competition. The contract supports military treatment facilities, veterans' healthcare programs, and other...
This federal contract award, with ID SPE2DB24D3013|SPE2DB25FFGYT, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,514.52 firm fixed-price delivery order is for the supply of 100 capsules of the drug Tacrolimus 1 mg, an immunosuppressant medication. The contract has an ultimate completion date of December 4, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC)...
This federal contract award, valued at $7,696.65, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TACROLIMUS 1 MG CAPSULE (IR) 100S, a medication used in various medical treatments. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, from the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the delivery of a specific pharmaceutical product, Tacrolimus 1 mg capsules, in a quantity of 100s. The contract is a Delivery Order with a Firm Fixed Price of $3,141.74 and an ultimate completion date of April 19, 2024. This award is not associated with a set-aside designation. Amerisourcebergen Drug Corp is a...
The federal contract award with ID SPE2DX15D1053|SPE2DX23F6LWJ was issued by the Defense Logistics Agency (DLA) Troop Support Medical, a defense agency, to the prime contractor Amerisourcebergen Drug Corp. The $5,493.45 firm fixed price delivery order is for the supply of 100 units of Tacrolimus 5 mg capsules. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which provides a comprehensive range of...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 100 capsules of the medication Tacrolimus 5 mg (immediate-release) and has a ceiling value of $4,419.13. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp is the prime contractor and does not have any major subcontractors identified. The contract is...
  • SPE2DB22D2206
    Indefinite Delivery Contract
  • SPE2DB22D2206-SPE2DB24FJA57
    Delivery Order

This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of Tacrolimus 5 mg capsules (immediate release) in 100-count units. The $3,871.10 contract is a firm fixed-price delivery order placed by the Defense Logistics Agency (DLA), a defense agency within the Department of Defense (DoD).

Amerisourcebergen, a major pharmaceutical distributor, holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued up to $999,999,999.00 through December 2025. This IDC serves as the primary vehicle for Amerisourcebergen to provide a wide range of pharmaceutical products and medical supplies to DLA facilities supporting the DoD worldwide. The company also holds a smaller IDC with the Department of Justice Federal Bureau of Investigation for similar medical commodities. This contract award does not have a set-aside designation.

Generated 10/1/24, 11:12 AM